TGFB1 and persistent truncus arteriosus: We detected a significant increase in TGF-β expression in mouse hearts 4 weeks after TAC, whereas jaranol treatment attenuated TAC-induced TGF-β expression, which is an important reason why jaranol protects against cardiac fibrosis.